AAAAAA

   
Results: 1-17 |
Results: 17
ABERRANT ANTIGEN EXPRESSION ANALYZED BY FLOW-CYTOMETRY IS AN MARKER OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
Authors: ITO S ISHIDA Y MURAI K KURIYA S
Citation: S. Ito et al., ABERRANT ANTIGEN EXPRESSION ANALYZED BY FLOW-CYTOMETRY IS AN MARKER OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA, Experimental hematology, 26(8), 1998, pp. 379-379
THE EXPRESSION OF WT1 IN MYELODYSPLASTIC SYNDROME
Authors: MURAI K ISHIDA Y ITO S NARIGASAWA Y YASHIMA A KURIYA S
Citation: K. Murai et al., THE EXPRESSION OF WT1 IN MYELODYSPLASTIC SYNDROME, Experimental hematology, 26(8), 1998, pp. 422-422
IN-VITRO AND IN-VIVO EFFECTS OF KT6352, A DERIVATIVE OF INDOLOCARBAZOLE COMPOUNDS, ON MURINE MEGAKARYOCYTOPOIESIS
Authors: SHIOTSU Y AKINAGA S YAMASHITA K MURAKATA C TAMAOKI T ISHIDA Y KURIYA S TERAMURA M MIZOGUCHI H
Citation: Y. Shiotsu et al., IN-VITRO AND IN-VIVO EFFECTS OF KT6352, A DERIVATIVE OF INDOLOCARBAZOLE COMPOUNDS, ON MURINE MEGAKARYOCYTOPOIESIS, Experimental hematology, 26(13), 1998, pp. 1195-1201
EFFECTS OF C-MPL LIGAND ON CYTOPLASMIC MATURATION OF MURINE MEGAKARYOCYTES AND ON PLATELET PRODUCTION
Authors: ISHIDA Y ITO T KURIYA S
Citation: Y. Ishida et al., EFFECTS OF C-MPL LIGAND ON CYTOPLASMIC MATURATION OF MURINE MEGAKARYOCYTES AND ON PLATELET PRODUCTION, The Journal of histochemistry and cytochemistry, 46(1), 1998, pp. 49-57
TREATMENT OF THE ANEMIA OF APLASTIC-ANEMIA PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER RANDOMIZED CONTROLLED-STUDY
Authors: BESSHO M HIRASHIMA K ASANO S IKEDA Y OGAWA N TOMONAGA M TOYAMA K NAKAHATA T NOMURA T MIZOGUCHI H YOSHIDA Y NIITSU Y KOHGO Y MIYAZAKI T TAKAMI H MIURA AB SASAKI H ABE K KURIYA S SHIGA Y SHIBATA A HAYASHI N MURAKAMI H MIYAWAKI S ENOKIHARA H TAKEMURA Y MIURA Y TAKAGI S TOYA K KOBAYASHI I KOMIYAMA A MITSUHASHI S MOTOYOSHI K SAKURAI M OHTA M YOSHIDA S HIGASHIHARA M HIRAI H MORI M MUTO Y HIROSAWA S HIROSE S OHSHIMA T TSURUOKA N OMINE M TSUKIMOTO I ONOZAWA Y AOKI I TSUNEMATSU Y KAWATO M YABE H KITAHARA M MATSUYAMA S AKATSUKA N HIRASAWA A AOYAGI Y NISHIHIRA H HIRANO M HOTTA T KODERA Y KOJIMA S MINAMI N OHTAKA S TAKIGUCHI T NAKAMURA T FUJIYAMA Y SUZUKI T AKIYAMA Y NAKAGAWA M MISAWA S HIBI S FUJII H MATSUZAWA Y KISHIMOTO T KITANI T OHSAWA N TATSUMI N KISHIDA T HIRAOKA A KAWA K NII M KONISHI S FUKUHARA S HORIUCHI A KAKISHITA E MATSUI T ISHIKAWA T OMOTO E YAWATA Y KOBAYASHI M KURAMOTO A DOHY H KANEKO T SHINOHARA K TAGUCHI H UCHIDA T TANAKA T KOSAKA M NIHO Y UEDA K ETO S MIYAZAKI S AMENOMORI M KAWAKITA M NISHIMURA H UIKE N NATORI H IKEDA S TAMURA K
Citation: M. Bessho et al., TREATMENT OF THE ANEMIA OF APLASTIC-ANEMIA PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - A MULTICENTER RANDOMIZED CONTROLLED-STUDY, European journal of haematology, 58(4), 1997, pp. 265-272
THE SIGNIFICANCE OF P21 WAF1 IN ENDOMITOSIS OF MURINE MEGAKARYOCYTES/
Authors: ISHIDA Y ONO Y ITO T KURIYA S FUJII H
Citation: Y. Ishida et al., THE SIGNIFICANCE OF P21 WAF1 IN ENDOMITOSIS OF MURINE MEGAKARYOCYTES/, Blood, 90(10), 1997, pp. 3479-3479
RECOMBINANT HUMAN INTERFERON-ALPHA-2B (RH IFN-ALPHA-2B) THERAPY FOR STEROID-RESISTANT IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
Authors: FUJIMURA K TAKAFUTA T KURIYA S ABE T AKATSUKA J YASUNAGA K UCHIDA T KAWAKITA M KITAMURA K NOMURA T KURAMOTO A
Citation: K. Fujimura et al., RECOMBINANT HUMAN INTERFERON-ALPHA-2B (RH IFN-ALPHA-2B) THERAPY FOR STEROID-RESISTANT IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), American journal of hematology, 51(1), 1996, pp. 37-44
A COMBINATION CHEMOTHERAPY WITH LOW-DOSES OF CYTARABINE AND ETOPOSIDEFOR HIGH-RISK MYELODYSPLASTIC SYNDROMES AND THEIR LEUKEMIC STAGE - A PILOT-STUDY
Authors: KURIYA S MURAI K MIYAIRI Y UTSUGISAWA T NARIGASAWA Y ITO T SHIMOSEGAWA K ISHIDA Y
Citation: S. Kuriya et al., A COMBINATION CHEMOTHERAPY WITH LOW-DOSES OF CYTARABINE AND ETOPOSIDEFOR HIGH-RISK MYELODYSPLASTIC SYNDROMES AND THEIR LEUKEMIC STAGE - A PILOT-STUDY, Cancer, 78(3), 1996, pp. 422-426
RECOMBINANT HUMAN C-MPL LIGAND IS NOT A DIRECT STIMULATOR OF PROPLATELET FORMATION IN MATURE HUMAN MEGAKARYOCYTES
Authors: ITO T ISHIDA Y KASHIWAGI R KURIYA S
Citation: T. Ito et al., RECOMBINANT HUMAN C-MPL LIGAND IS NOT A DIRECT STIMULATOR OF PROPLATELET FORMATION IN MATURE HUMAN MEGAKARYOCYTES, British Journal of Haematology, 94(2), 1996, pp. 387-390
ANALYSIS OF S-PHASE AND PLOIDY DISTRIBUTION IN MEGAKARYOCYTES OF UNFRACTIONATED MURINE BONE-MARROW
Authors: ISHIDA Y ITOH T KURIYA S
Citation: Y. Ishida et al., ANALYSIS OF S-PHASE AND PLOIDY DISTRIBUTION IN MEGAKARYOCYTES OF UNFRACTIONATED MURINE BONE-MARROW, Blood, 88(10), 1996, pp. 3192-3192
TETRASOMY OF PHILADELPHIA-CHROMOSOME IN MYELOBLASTIC CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: OIKAWA H UTSUGISAWA T MURAI K NARIGASAWA Y MIYAIRI Y SHIMOSEGAWA K SUZUKI T KURIYA S
Citation: H. Oikawa et al., TETRASOMY OF PHILADELPHIA-CHROMOSOME IN MYELOBLASTIC CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA, International journal of hematology, 61(4), 1995, pp. 229-230
EFFECTS OF RH C-MPL LIGAND ON MURINE MEGAKARYOCYTES
Authors: ISHIDA Y ITOH T MURAI K MIYAIRI Y UTSUGISAWA T NARIGASAWA Y KURIYA S
Citation: Y. Ishida et al., EFFECTS OF RH C-MPL LIGAND ON MURINE MEGAKARYOCYTES, Blood, 86(10), 1995, pp. 2773-2773
EFFECT OF C-MPL LIGAND ON PROPLATELET FORMATION OF HUMAN MEGAKARYOCYTES
Authors: ITO T ISHIDA Y KURIYA S
Citation: T. Ito et al., EFFECT OF C-MPL LIGAND ON PROPLATELET FORMATION OF HUMAN MEGAKARYOCYTES, Blood, 86(10), 1995, pp. 2775-2775
INTERLEUKIN-6 AND ERYTHROPOIETIN ACT AS DIRECT POTENTIATORS AND INDUCERS OF IN-VITRO CYTOPLASMIC PROCESS FORMATION ON PURIFIED MOUSE MEGAKARYOCYTES
Authors: AN E OGATA K KURIYA S NOMURA T
Citation: E. An et al., INTERLEUKIN-6 AND ERYTHROPOIETIN ACT AS DIRECT POTENTIATORS AND INDUCERS OF IN-VITRO CYTOPLASMIC PROCESS FORMATION ON PURIFIED MOUSE MEGAKARYOCYTES, Experimental hematology, 22(2), 1994, pp. 149-156
A NOVEL MEGAKARYOCYTE POTENTIATOR PRODUCED BY MC-1 HUMAN LUNG-CANCER CELL-LINE
Authors: KURIYA S OGATA K AN E HAMAGUCHI H YOKOSE N ANZAI Y NOMURA T
Citation: S. Kuriya et al., A NOVEL MEGAKARYOCYTE POTENTIATOR PRODUCED BY MC-1 HUMAN LUNG-CANCER CELL-LINE, Pathobiology, 61(5-6), 1993, pp. 256-267
CLINICAL AND CYTOGENETIC FINDINGS OF MYELODYSPLASTIC SYNDROMES SHOWING HYPOCELLULAR BONE-MARROW OR MINIMAL DYSPLASIA, IN COMPARISON WITH TYPICAL MYELODYSPLASTIC SYNDROMES
Authors: TOYAMA K OHYASHIKI K YOSHIDA Y ABE T ASANO S HIRAI H HIRASHIMA K HOTTA T KURAMOTO A KURIYA S MIYAZAKI T KAKISHITA E MIZOGUCHI H MORI M SHIRAKAWA S TAKAKU F TOMONAGA M UCHINO H URABE A YASUNAGA K NOMURA T
Citation: K. Toyama et al., CLINICAL AND CYTOGENETIC FINDINGS OF MYELODYSPLASTIC SYNDROMES SHOWING HYPOCELLULAR BONE-MARROW OR MINIMAL DYSPLASIA, IN COMPARISON WITH TYPICAL MYELODYSPLASTIC SYNDROMES, International journal of hematology, 58(1-2), 1993, pp. 53-61
CLINICAL IMPLICATIONS OF CHROMOSOMAL-ABNORMALITIES IN 401 PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A MULTICENTRIC STUDY IN JAPAN
Authors: TOYAMA K OHYASHIKI K YOSHIDA Y ABE T ASANO S HIRAI H HIRASHIMA K HOTTA T KURAMOTO A KURIYA S MIYAZAKI T KAKISHITA E MIZOGUCHI H OKADA M SHIRAKAWA S TAKAKU F TOMONAGA M UCHINO H YASUNAGA K NOMURA T
Citation: K. Toyama et al., CLINICAL IMPLICATIONS OF CHROMOSOMAL-ABNORMALITIES IN 401 PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A MULTICENTRIC STUDY IN JAPAN, Leukemia, 7(4), 1993, pp. 499-508
Risultati: 1-17 |